Eija Korkeila - UTU Research Portal

Eija Korkeila

- Docent,
Department of Clinical Medicine (Faculty of Medicine)

eija.korkeila@utu.fi

Publications

Lymfoomahoitojen jälkeiset pitkäaikaishaitat, niiden ehkäisy ja seuranta (2020)
- Duodecim
Sunela Kaisa, Leppä Sirpa, Kuittinen Outi, Tinkanen Helena, Tuohinen Suvi, Schmitt Florence, Korkeila Eija; Suomen Lymfoomaryhmä
(A2 Refereed review article in a scientific journal )
CDX2 Loss With Microsatellite Stable Phenotype Predicts Poor Clinical Outcome in Stage II Colorectal Carcinoma (2019)
- American Journal of Surgical Pathology
Khadija Slik, Riku Turkki, Olli Carpén, Samu Kurki, Eija Korkeila, Jari Sundström, Teijo Pellinen
(A1 Refereed original research article in a scientific journal)
Combined epithelial marker analysis of tumour budding in stage II colorectal cancer (2019)
- Journal of Pathology: Clinical Research
Khadija Slik, Sami Blom, Riku Turkki, Katja Välimäki, Samu Kurki, Harri Mustonen, Caj Haglund, Olli Carpén, Olli Kallioniemi, Eija Korkeila, Jari Sundström, Teijo Pellinen
(A1 Refereed original research article in a scientific journal)
Incidence of solid cancer in patients with follicular lymphoma (2019)
- Acta Oncologica
Sorigue M, Prusila REI, Jauhiainen J, Mercadal S, Postila A, Salmi P, Tanhua T, Tikkanen S, Kakko S, Kuitunen H, Pollari M, Nystrand I, Kuusisto MEL, Vasala K, Jantunen E, Korkeila E, Karihtala P, Sancho JM, Turpeenniemi-Hujanen T, Kuittinen O
(A1 Refereed original research article in a scientific journal)
Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era (2019)
- British Journal of Haematology
Roosa E. I. Prusila, Marc Sorigue, Jyrki Jauhiainen, Santiago Mercadal, Aleksi Postila, Petteri Salmi, Taru Tanhua, Susanna Tikkanen, Sakari Kakko, Hanne Kuitunen, Marjukka Pollari, Ilja Nystrand, Milla E. L. Kuusisto, Kaija Vasala, Esa Jantunen, Eija Korkeila, Peeter Karihtala, Juan‐Manuel Sancho, Taina Turpeenniemi‐Hujanen, Outi Kuittinen
(A1 Refereed original research article in a scientific journal)
EGFR gene copy number decreases during anti-EGFR antibody therapy in colorectal cancer (2018)
- Human Pathology
Eva-Maria Birkman, Tuulia Avoranta, Annika Ålgars, Eija Korkeila, Minnamaija Lintunen, Laura Lahtinen, Teijo Kuopio, Raija Ristamäki, Olli Carpén, Jari Sundström
(A1 Refereed original research article in a scientific journal)
Ezrin-ekspression analysoinnista apua stage II -kolorektaalisyövän ennusteen arvioinnissa (2018)
- BestPractice Onkologia ja hematologia
Eija Korkeila
(D1 Article in a professional journal)
Haimasyövän nykyhoito (2018)
- Lääkärilehti
Saila Kauhanen, Arto Kokkola, Eija Korkeila, Arto Saarela, Pauli Puolakkainen
(A2 Refereed review article in a scientific journal )
Protein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer (2018)
- Cancer Medicine
Eva-Maria Birkman, Adam Elzagheid, Terhi Jokilehto, Tuulia Avoranta, Eija Korkeila, Jarmo Kulmala, Kari Syrjänen, Jukka Westermarck, Jari Sundström
(A1 Refereed original research article in a scientific journal)
Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer (2017)
- PLoS ONE
Slik K, Kurki S, Korpela T, Carpen O, Korkeila E, Sundstrom J
(A1 Refereed original research article in a scientific journal)
Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer (2017)
- Supportive Care in Cancer
Korkeila EA, Salminen T, Kallio R, Mikkola M, Auvinen P, Pyrhönen S, Ristamäki R
(A1 Refereed original research article in a scientific journal)
Advanced pancreatic cancer-how to choose an adequate treatment option (2015)
- World Journal of Gastroenterology
Korkeila E.
(A2 Refereed review article in a scientific journal )
Haimasyövän ilmaantuvuus, diagnostiikka ja ennuste Suomessa (2015)
- BestPractice
Eija Korkeila
(Other publication)
Protein phosphatase methylesterase-1 (PME-1) expression predicts a favorable clinical outcome in colorectal cancer (2015)
- Cancer Medicine
Kaur A, Elzagheid A, Birkman EM, Avoranta T, Kytölä V, Korkeila E, Syrjänen K, Westermarck J, Sundström J
(A1 Refereed original research article in a scientific journal)
ALDH1 expression indicates chemotherapy resistance and poor outcome in node-negative rectal cancer (2013)
- Human Pathology
Avoranta ST, Korkeila EA, Ristamäki RH, Syrjänen KJ, Carpén OM, Pyrhönen SO, Sundström JT
(A1 Refereed original research article in a scientific journal)
Feed Back (2013)
- Nuori lääkäri
Korkeila Eija
(D1 Article in a professional journal)
Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence (2012)
- World Journal of Gastroenterology
Suvi Tuulia Avoranta, Eija Annika Korkeila, Kari Juhani Syrjänen, Seppo Olavi Pyrhönen, Jari Toivo Tapio Sundström
(A1 Refereed original research article in a scientific journal)
Carbonic anhydrase IX, hypoxia-inducible factor-1?, ezrin and glucose transporter-1 as predictors of disease outcome in rectal cancer. Multivariate Cox survival models following data reduction by principal component analysis of the clinicopathological predictors (2011)
- Anticancer Research
Korkeila Eija A, Sundström Jari, Pyrhönen Seppo, Syrjänen Kari
(A1 Refereed original research article in a scientific journal)
Preoperative radiotherapy downregulates the nuclear expression of hypoxia-inducible factor-1 alpha in rectal cancer (2010)
- Scandinavian Journal of Gastroenterology
Korkeila E, Jaakkola PM, Syrjanen K, Sundstrom J, Pyrhonen S
(A1 Refereed original research article in a scientific journal)
The expression and distribution of group IIA phospholipase A2 in human colorectal tumours (2010)
- Virchows Archiv
Avoranta T, Sundström J, Korkeila E, Syrjänen K, Pyrhönen S, Laine J
(A1 Refereed original research article in a scientific journal)